期刊文献+

BCAP37-hIL-18基因疫苗抗乳腺癌作用研究 被引量:1

A study of anti-breast cancer effect by BCAP37-IL-18 gene vaccine
下载PDF
导出
摘要 目的为乳腺癌基因工程疫苗的临床应用奠定基础。方法采用MTT法检测经高能X线照射灭活BCAP37-hIL-18基因疫苗(下简称基因疫苗)的生存曲线,以及其刺激T细胞增殖的能力。结果经过高能X线照射后,BCAP37-hIL-18细胞生长停滞。基因疫苗作用T细胞的反应值及刺激率提高,荷瘤小鼠的肿瘤缩小,生存时间延长,生存率提高。结论BCAP37-hIL-18疫苗具有明显抗肿瘤作用;本研究为乳腺癌基因工程肿瘤疫苗的研制及临床应用提供了实验基础。 [Objective] To study the anti-breast cancer effect of BCAP37-hIL-18 gene vaccine. [Methods] The growth curve and the ability to stimulate T cells of BCAP37-hIL-18 gene vaccine irradiated by high intensity X grays were measured by MTT method. [Results] Irradiated by high intensity X grays, the growth rate of BCAP37-hIL-18 in vivo was stopped, BCAP37-hIL-18 can enhance the stimulation of T cells, Tumor formation by parental BCAP37 cells was significantly delayed in mice than those had been immunized with BCAP37-hIL-18, and enhanced survive rates. [Conclusions] It indicated that BCAP37-hIL-18 have some anti-breast cancer effects, and BCAP37 cells transduced with IL-18 gene might be used as human breast cancer vaccine.
出处 《山东医药》 CAS 北大核心 2007年第8期13-14,共2页 Shandong Medical Journal
关键词 白细胞介素-18 乳腺肿瘤 免疫疗法 interleukin-18 breast tumor immunotherapy
  • 相关文献

参考文献1

共引文献13

同被引文献21

  • 1Micke P, Hengstler JG, Ros R, et al. C-erbB-2 expression in small-cell lung cancer is associated with poor prognosis[J]. Int J Cancer, 2001,92(4):474-479.
  • 2Aoyagi K, Miyake Y, Urakami K, et al. Enzyme immunoassay of immunoreactive progastrin-releasing peptide (31-98) as tumor marker for small-cell lung carcinorma: Development and Evaluation[J]. Clin Chem, 1995,41(4):537-543.
  • 3Stieber P, Dinemann H, Schalhorn A, et al. Pro-gastrin-releasing Peptide (ProGRP)-A useful marker in small cell lung carcinomas[J]. Anticancer Res,1999,19(4A):2673-2678.
  • 4Bubanov ic G, Pavi cevi c R, Franjev i c A. Determining the cut-off value of pro-gastrin relearning peptide (ProGRP) in lung cancer according to population characteristics [J]. Coll Antropol, 2008,32(4): 1155-1164.
  • 5Wild J, Bieler K, Kostler J, et al. Preelinical evaluation of the immunogenicity of C-TYPe HIV-l-based DNA and NY- VAC vaccines in the Balb/c mouse model[J]. Viral Immunol, 2009, 22(5): 309-319.
  • 6Winther B, Nordlund M, Paus E, et al. Immuno-capture as ultimate sample cleanup in LC-MS/MS determination of the early stage biomarker ProGRP [J]. J Sep Sci,2009,32(17): 2937-2943.
  • 7Rizvi SM, Goodwill J, Lim E, et al. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas[J].Histopathology, 2009,55(3):332-337.
  • 8Ohwada A, Nagaoka I, Takahashi F, et al. DNA vaccination against HuD antigen elicits antitumor activity in a small-cell lung cancer murine model [J]. Am J Respir Cell Mol Biol, 1999,21(1):37-43.
  • 9Zheng Y, Zhao WM, Wang H, et al. Codon usage bias in Chlamydia trachomias and the effect of codon modification of the MOMP gene on immune responses to vaccination [J]. Biochem Cell Biol, 2007,85(2):218-226.
  • 10Durrant L G,Ramage J M.Development of cancer vaccines to activate cytotoxic t lymphocytes [J].Expert Opin Biol Ther, 2005,5(4):555-563.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部